Showing results (1-10 of 316) with videos related to

Sort By:
Pageof 32
Molecular Psychiatry|July 24, 2023
Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patientsLiron Mizrahi, Ashwani Choudhary, Polina Ofer, et al.
Drug Development Research|March 5, 2020
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeuticsDavid Gurwitz
Dialogues in Clinical Neuroscience|October 23, 2019
Genomics and the future of psychopharmacology: MicroRNAs offer novel therapeuticsDavid Gurwitz
Personalized Medicine|May 24, 2018
Workshop AbstractsDavid Gurwitz
Dialogues in Clinical Neuroscience|October 21, 2016
Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disordersDavid Gurwitz
Drug Development Research|May 19, 2020
Repurposing current therapeutics for treating COVID-19: A vital role of prescription records data miningDavid Gurwitz
Personalized Medicine|May 26, 2018
Personalized medicine in psychiatryDavid Gurwitz
Pharmacogenomics|April 27, 2010
Pharmacogenetics education: 10 years of experience at Tel Aviv UniversityDavid Gurwitz
Drug Development Research|September 9, 2014
Microarray gene and miRNA expression studies: looking for new therapeutic targets for frontotemporal lobar degenerationElena Milanesi, Andrea Pilotto
Journal of Molecular Neuroscience : MN|March 6, 2015
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder PatientsElena Milanesi, Adva Hadar, Elisabetta Maffioletti, et al.
Pageof 32